# OnCo record oncodesign-precision-medicine (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/oncodesign-precision-medicine/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "oncodesign-precision-medicine" ;
  schema:name "Oncodesign Precision Medicine"@en ;
  schema:alternateName "OPM"@en ;
  schema:description "Oncodesign Precision Medicine is a small French company developing kinase-blocking medicines. Its OPM-101 is being prepared for a trial with pembrolizumab in advanced melanoma that no longer responds to immunotherapy."@en ;
  schema:url <https://onco.cc/companies/oncodesign-precision-medicine/>, <https://www.oncodesign.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.oncodesign.com/>, <https://www.oncodesign.com/wp-content/uploads/2026/10/PR_OPM_HYR-26_EN_22102026.pdf>, <https://clinicaltrials.gov/study/NCT07040436> ;
  schema:addressCountry "FR" ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> .